AI Visibility Scorecard
ARALAST NP Infusion For Severe Alpha1-Antitrypsin Deficiency
aralast.com · Healthcare
Borderline visible. AI bots can crawl ARALAST NP Infusion For Severe Alpha1-Antitrypsin Deficiency, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 2 times
Claude · Parallel
#705,461 of 925,440 in Healthcare for AI visibility
6
AI Naming Predictability
iRarely named · 6/100
Healthcare average 11
Top 67% of Healthcare
See what's behind this score →3.5
-
Network Authority
iNot connected yet
0 relationships on record. Businesses in Healthcare average 3. Claim your page and Engagemii is your first.
See what's behind this score →45
Muse Index Score
iAI agent readiness
Transactable · 45/100
Healthcare average 18
See what's behind this score →0
About ARALAST NP Infusion For Severe Alpha1-Antitrypsin Deficiency
from our crawl and measurement
ARALAST NP Infusion For Severe Alpha1-Antitrypsin Deficiency, based in Cambridge, MA, describes itself simply: "ARALAST NP [Alpha1-Proteinase Inhibitor (Human)] is a medication for severe Alpha1 antitrypsin deficiency with emphysema. See Important Safety Information." To AI engines like ChatGPT and Perplexity, though, it is barely visible: it scores 3.5 out of 10.
Our crawl found structured data on the page (MedicalWebPage) and a readable heading structure. It is missing an llms.txt file and a sitemap.
AI crawlers have visited once in our tracking, including ClaudeBot (Anthropic).
- Company ·
- ARALAST NP Infusion For Severe Alpha1-Antitrypsin Deficiency
- Website ·
- aralast.com
- Industry ·
- Healthcare
- Location ·
- Cambridge, MA
- Site status ·
- Live (The website showed an active business site when last checked (Oct 31, 2026).)
- Last scored ·
- Sep 29, 2026
The 6 on-page signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Strong
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Strong
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Good
Sitemaps and entity links AI can follow.
The 6 off-page signals AI reads
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can read your site and name it in answers. At 3.5/10, ARALAST NP Infusion For Severe Alpha1-Antitrypsin Deficiency is crawlable but under-signaled - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for ARALAST NP Infusion For Severe Alpha1-Antitrypsin Deficiency
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
How to Get Your Company Named by ChatGPT, Gemini, and Claude
When a buyer asks ChatGPT which company to use, two different things can happen. ChatGPT can name a company in its answer. Or it can link to a web page as a source. Most advice about AI visibility is about the second one. Our data says the first one is what matters.
Continue reading in your free Engagemii portalSign up free to read the full article and get your AEO fix list for ARALAST NP Infusion For Severe Alpha1-Antitrypsin Deficiency.
Source & Attribution
Scored by Engagemii on September 29, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/aralast
Cite this score: Engagemii (2026). "AEO Score for ARALAST NP Infusion For Severe Alpha1-Antitrypsin Deficiency." Retrieved from https://engagemii.com/aeo/brands/aralast
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform